Arcturus Therapeutics Ltd (ARCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,449 | -32,834 | -10,548 | -1,579 | -3,929 |
| Depreciation Amortization | 51 | 31 | 9 | 7 | 6 |
| Accounts receivable | N/A | N/A | N/A | 12 | -49 |
| Accounts payable and accrued liabilities | -248 | 258 | 24 | -101 | 95 |
| Other Working Capital | -1,115 | 388 | 1,646 | -37 | 9 |
| Other Operating Activity | 2,613 | 3,831 | 1,516 | 115 | 1,507 |
| Operating Cash Flow | $-18,148 | $-28,326 | $-7,353 | $-1,583 | $-2,361 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -14,500 | 8,486 | -28,008 | 517 | -517 |
| PPE Investments | -181 | -79 | -39 | N/A | -24 |
| Purchase Of Investment | -19,000 | N/A | N/A | N/A | N/A |
| Sale Of Investment | -161 | N/A | N/A | 507 | -500 |
| Investing Cash Flow | $-33,842 | $8,407 | $-28,047 | $1,024 | $-1,041 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 115 | 600 | 450 |
| Common Stock Issued | 66,459 | N/A | 57,254 | 1 | 2,170 |
| Other Financing Activity | 13 | 0 | 29 | 0 | 0 |
| Financing Cash Flow | $66,472 | $N/A | $57,398 | $601 | $2,620 |
| Beginning Cash Position | 2,176 | 22,095 | 97 | 55 | 837 |
| End Cash Position | 16,658 | 2,176 | 22,095 | 97 | 55 |
| Net Cash Flow | $14,482 | $-19,919 | $21,998 | $42 | $-782 |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,148 | -28,326 | -7,353 | -1,583 | -2,361 |
| Capital Expenditure | -181 | -79 | -39 | N/A | -24 |
| Free Cash Flow | -18,329 | -28,405 | -7,392 | -1,583 | -2,385 |